Dexcom Inc. stock (US2521311074): Is continuous glucose monitoring strong enough to drive U.S. investor upside?

Dexcom leads in real-time diabetes tech that's changing lives and markets for millions of U.S. patients. For investors eyeing healthcare growth amid aging demographics, this Nasdaq stock offers a focused play on innovation. ISIN: US2521311074